Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuan-Yin Shen

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal for Immunotherapy of Cancer|October 2, 2021
Activation of GM-CSF and TLR2 signaling synergistically enhances antigen-specific antitumor immunity and modulates the tumor microenvironmentWan-Lun Yan, Chiao-Chieh Wu, Kuan-Yin Shen, et al.
Expert Review of Vaccines|December 3, 2014
Self-adjuvanting lipoimmunogens for therapeutic HPV vaccine development: potential clinical impactKuan-Yin Shen, Li-Sheng Chang, Chih-Hsiang Leng, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a Toll-like receptor agonist-conjugated peptideKuan-Yin Shen, Ying-Chyi Song, I-Hua Chen, et al.
Immunotherapy|March 18, 2017
Recent progress in GM-CSF-based cancer immunotherapyWan-Lun Yan, Kuan-Yin Shen, Chun-Yuan Tien, et al.
Oncotarget|April 30, 2016
A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells populationChiao-Chieh Wu, Shih-Jen Liu, Hsin-Wei Chen, et al.
European Journal of Immunology|December 18, 2007
Increased TLR responses in dendritic cells lacking the ITAM-containing adapters DAP12 and FcRgammaChing-Liang Chu, Yen-Ling Yu, Kuan-Yin Shen, et al.
Cancers|April 2, 2020
Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic CellsKuan-Yin Shen, Hsin-Yu Liu, Wan-Lun Yan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 2014
Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cellsKuan-Yin Shen, Ying-Chyi Song, I-Hua Chen, et al.
European Journal of Immunology|August 25, 2009
A triterpenoid methyl antcinate K isolated from Antrodia cinnamomea promotes dendritic cell activation and Th2 differentiationYen-Ling Yu, I-Hua Chen, Kuan-Yin Shen, et al.
Vaccines|October 24, 2020
A Polypeptide of Tumor-Associated Antigen L6 with Intrinsic Adjuvant Activity Enhances Antitumor ImmunityYuh-Pyng Sher, Kit Man Chai, Wen-Ching Chen, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal for Immunotherapy of Cancer|October 2, 2021
Activation of GM-CSF and TLR2 signaling synergistically enhances antigen-specific antitumor immunity and modulates the tumor microenvironmentWan-Lun Yan, Chiao-Chieh Wu, Kuan-Yin Shen, et al.
Expert Review of Vaccines|December 3, 2014
Self-adjuvanting lipoimmunogens for therapeutic HPV vaccine development: potential clinical impactKuan-Yin Shen, Li-Sheng Chang, Chih-Hsiang Leng, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a Toll-like receptor agonist-conjugated peptideKuan-Yin Shen, Ying-Chyi Song, I-Hua Chen, et al.
Immunotherapy|March 18, 2017
Recent progress in GM-CSF-based cancer immunotherapyWan-Lun Yan, Kuan-Yin Shen, Chun-Yuan Tien, et al.
Oncotarget|April 30, 2016
A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells populationChiao-Chieh Wu, Shih-Jen Liu, Hsin-Wei Chen, et al.
European Journal of Immunology|December 18, 2007
Increased TLR responses in dendritic cells lacking the ITAM-containing adapters DAP12 and FcRgammaChing-Liang Chu, Yen-Ling Yu, Kuan-Yin Shen, et al.
Cancers|April 2, 2020
Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic CellsKuan-Yin Shen, Hsin-Yu Liu, Wan-Lun Yan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 2014
Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cellsKuan-Yin Shen, Ying-Chyi Song, I-Hua Chen, et al.
European Journal of Immunology|August 25, 2009
A triterpenoid methyl antcinate K isolated from Antrodia cinnamomea promotes dendritic cell activation and Th2 differentiationYen-Ling Yu, I-Hua Chen, Kuan-Yin Shen, et al.
Vaccines|October 24, 2020
A Polypeptide of Tumor-Associated Antigen L6 with Intrinsic Adjuvant Activity Enhances Antitumor ImmunityYuh-Pyng Sher, Kit Man Chai, Wen-Ching Chen, et al.
Pageof 3